The Latest Breaking News from BiomX

Doctors Have Given Patients Bacteria Killing Viruses for a Century, and Regulators Still Have Not Approved a Single One

Phage therapy has one positive randomized result and no FDA approval. The bottleneck is matching a strain-specific virus to each patient.

Medical Daily · Aug 13

BiomX Awaits FDA Clearance To Restart Cystic Fibrosis Trial After Nebulizer Device Review

BiomX Inc. (NYSE:PHGE) on Tuesday announced that the U.S. Food and Drug Administration (FDA) is continuing its evaluation of the nebulizer device used for drug administration in the company's Phase 2b trial of BX004 in cystic fibrosis patients.

Benzinga · Nov 26, 2025

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga · Jul 6, 2022